DE60117788D1 - Menschliche wingless-änhliche gene - Google Patents

Menschliche wingless-änhliche gene

Info

Publication number
DE60117788D1
DE60117788D1 DE60117788T DE60117788T DE60117788D1 DE 60117788 D1 DE60117788 D1 DE 60117788D1 DE 60117788 T DE60117788 T DE 60117788T DE 60117788 T DE60117788 T DE 60117788T DE 60117788 D1 DE60117788 D1 DE 60117788D1
Authority
DE
Germany
Prior art keywords
genes
enough
wingless
human
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60117788T
Other languages
English (en)
Other versions
DE60117788T2 (de
Inventor
Klaus Duecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of DE60117788D1 publication Critical patent/DE60117788D1/de
Publication of DE60117788T2 publication Critical patent/DE60117788T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60117788T 2000-05-03 2001-04-30 Menschliche wingless-ähnliche gene Expired - Lifetime DE60117788T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00109422 2000-05-03
EP00109422 2000-05-03
PCT/EP2001/004887 WO2001083543A1 (en) 2000-05-03 2001-04-30 Human wingless-like gene

Publications (2)

Publication Number Publication Date
DE60117788D1 true DE60117788D1 (de) 2006-05-04
DE60117788T2 DE60117788T2 (de) 2006-11-02

Family

ID=8168611

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60117788T Expired - Lifetime DE60117788T2 (de) 2000-05-03 2001-04-30 Menschliche wingless-ähnliche gene

Country Status (8)

Country Link
US (1) US7033770B2 (de)
EP (1) EP1278770B1 (de)
JP (1) JP2003531635A (de)
AT (1) ATE319739T1 (de)
CA (1) CA2407959C (de)
DE (1) DE60117788T2 (de)
ES (1) ES2258090T3 (de)
WO (1) WO2001083543A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713526B2 (en) * 2001-05-01 2010-05-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
WO2002088081A2 (en) 2001-05-01 2002-11-07 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
US7873723B2 (en) * 2003-01-30 2011-01-18 Hewlett-Packard Development Company, L.P. Device data
DE10361444A1 (de) * 2003-12-23 2005-07-21 Axaron Bioscience Ag Verfahren zur in vitro Differenzierung neuronaler Stammzellen oder von neuronalen Stammzellen abgeleiteter Zellen
US20090311243A1 (en) * 2005-05-30 2009-12-17 Astrazeneca Ab Methods for Identifying FZD8 Modulators and the Use of such Modulators for Treating Osteoarthritis
EP3212188B1 (de) * 2014-10-29 2020-02-12 King Abdullah University Of Science And Technology 3-alkyl-pyridiniumverbindung aus schwämmen aus dem roten meer mit starker antiviraler wirkung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0885959A3 (de) * 1997-05-23 2000-01-12 Smithkline Beecham Plc Menschlisches Wnt-5b Protein
EP0882791A3 (de) * 1997-05-23 2000-01-12 Smithkline Beecham Plc WNT-11 Polypeptiden
JP2002501744A (ja) * 1998-01-30 2002-01-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Ｗｎｔ−１０ａ
US20020123103A1 (en) * 1999-11-22 2002-09-05 Holloway James L. Human Wnt gene
WO2001038353A2 (en) * 1999-11-22 2001-05-31 Zymogenetics, Inc. Human wnt gene
US20030083244A1 (en) * 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same

Also Published As

Publication number Publication date
US7033770B2 (en) 2006-04-25
ATE319739T1 (de) 2006-03-15
CA2407959C (en) 2013-06-11
ES2258090T3 (es) 2006-08-16
JP2003531635A (ja) 2003-10-28
EP1278770B1 (de) 2006-03-08
US20030175805A1 (en) 2003-09-18
WO2001083543A1 (en) 2001-11-08
DE60117788T2 (de) 2006-11-02
EP1278770A1 (de) 2003-01-29
CA2407959A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
ATE291086T1 (de) An entzündlichen darmerkrankungen beteiligte gene und deren verwendung
EP0939124A3 (de) MBGP1-Sequenzen
BR0111877A (pt) Compostos
WO2001066690A3 (en) Novel compounds
ATE319739T1 (de) Menschliche wingless-änhliche gene
WO2001072961A3 (en) Novel compounds
DE69836333D1 (de) Neisseria lactoferrin-bindendes protein
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2001032864A3 (en) Gpcr-kd5 polypeptides and dna sequences thereof
EP0885959A3 (de) Menschlisches Wnt-5b Protein
AU8394601A (en) A novel member of the epha receptor family
DE69935213D1 (de) Basb019 proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
WO2002004600A3 (en) Novel compounds
WO2001004141A3 (de) Seripancrin
WO2001068816A8 (en) Human histamine h3 gene variant-3
DK1257573T3 (da) Hidtil ukendt transskriptionsfaktor CARP-2
DK1309690T3 (da) MFQ-111, et humant GTPase-lignende protein
WO2000053628A3 (en) Genes encoding human potassium channel proteins
DE60136643D1 (de) Neuromedin u delta polypeptide
WO2001068703A8 (en) Human histamine h3 gene variant-2
WO2001072963A3 (en) Novel human uridine kinase
WO2001079269A3 (en) Lipid binding protein 4
WO2001029178A3 (en) Epo primary response gene 1, eprg1
WO2002008252A3 (en) Novel protein containing ring finger domaine r1p4
DK1266008T3 (da) Akut neuroninduceret calciumbindende protein type 1-ligand

Legal Events

Date Code Title Description
8364 No opposition during term of opposition